系统性炎症疾病患者冠脉血管扩张储备受损与不良预后相关
本研究回顾性纳入198例类风湿关节炎、系统性红斑狼疮或银屑病患者,行静息-负荷心肌灌注PET测定心肌血流量及心肌血流储备(MFR)。中位随访7.8年,MFR最低三分位(<1.65)患者全因死亡和MACE风险显著高于最高三分位,提示冠脉血管扩张储备受损与不良心血管结局相关。
要点
- MFR最低三分位(<1.65)患者全因死亡风险增高(校正后HR 2.4)。
- MFR最低三分位患者MACE风险显著增高(校正后HR 3.6)。
- 三种炎症疾病间平均MFR无差异,MFR可用于此类患者风险分层。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to evaluate the prognostic value of quantitative myocardial blood flow (MBF) and myocardial flow reserve (MFR), reflecting the integrated effects of diffuse atherosclerosis and microvascular dysfunction in patients with systemic inflammatory disorders.
BACKGROUND: Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and psoriasis (PsO) are common inflammatory conditions with excess cardiovascular (CV) risk compared to the general population. Systemic inflammation perturbs endothelial function and has been linked to coronary vasomotor dysfunction. However, the prognostic significance of this vascular dysfunction is not known.
METHODS: This was a retrospective study of patients with RA, SLE, and PsO undergoing clinically indicated rest and stress myocardial perfusion positron emission tomography (PET). Patients with an abnormal myocardial perfusion study or left ventricular dysfunction were excluded. MFR was calculated as the ratio of myocardial blood flow (MBF, ml/min/g) at peak stress compared to that at rest.
RESULTS: Among the 198 patients (median age: 65 years; 80% female), 20.7% had SLE, 31.8% had PsO, and 47.5% had RA. There were no differences in mean MFR between these conditions. Over a median follow-up of 7.8 years, there were 51 deaths and 63 major adverse cardiovascular events (MACE). Patients in the lowest tertile (MFR <1.65) had higher all-cause mortality than the highest tertile, which remained significant after adjusting for age, sex, and the pre-test clinical risk score (hazard ratio [HR]: 2.4; 95% confidence interval [CI]: 1.05 to 5.4; p = 0.038). Similarly, compared to the highest MFR tertile, those in the lowest tertile had a lower MACE-free survival after adjusting for age, sex, and the pre-test clinical risk score (HR: 3.6; 95% CI: 1.7 to 7.6; p = 0.001).
CONCLUSIONS: In patients with systemic inflammatory disorders, impaired coronary vasodilator reserve was associated with worse cardiovascular outcomes and all-cause mortality.
引用
- Weber BN, Stevens E, Perez-Chada LM, et al. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021. PMID: 33744132. doi:10.1016/j.jcmg.2020.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。